Blood Preparation Market Report 2025

The blood preparation market size has grown strongly in recent years. It will grow from $48.03 billion in 2024 to $51.28 billion in 2025 at a compound annual growth rate (CAGR) of 6.7%. The growth in the historic period can be attributed to rise in blood transfusion procedures, increasing prevalence of blood disorders, growing awareness of blood safety, global initiatives for blood donation, government regulations and standards.

The blood preparation market size is expected to see strong growth in the next few years. It will grow to $66.59 billion in 2029 at a compound annual growth rate (CAGR) of 6.8%. The growth in the forecast period can be attributed to rising demand for blood components, personalized medicine approaches, emerging therapies and applications, global healthcare infrastructure development. Major trends in the forecast period include automation and integration of blood processing systems, demand for pathogen-reduced blood components, customization and personalization in blood components, focus on platelet-rich plasma (PRP) and platelet-rich fibrin (PRF), regulatory compliance and stringent quality standards.

The increasing global blood donations are set to drive the growth of the blood preparation market. Blood donation involves the altruistic act of contributing blood for medical use, sustaining life through transfusions crucial in surgeries, cancer treatment, chronic illnesses, and trauma care. This process ensures the availability of blood whenever and wherever needed during preparation. For example, National Blood Service Ghana reported a rise in blood collections, from 156,453 units in 2020 to 173,938 units in 2021. Additionally, World Bank data indicated an 86% surge in blood collections from June 2020 to June 2021, reaching 186,239 units, catering to over 214,187 individuals. Therefore, the increase in blood donations propels the blood preparation market's growth.

The rise in blood-related disorders is anticipated to boost the blood preparation market. These disorders encompass diverse conditions such as blood cancers that impact blood components, functions, or clotting abilities, often necessitating transfusions or specialized treatments. Instances of deficiencies in clotting factors, red blood cells, or platelets drive the need for blood preparation. For instance, Blood Cancer UK revealed that around 41,000 individuals receive blood cancer diagnoses annually in the UK, with approximately 250,000 currently living with this condition. Statistics indicate a one in 16 men and one in 22 women likelihood of developing blood cancer during their lifetime. Hence, the increasing prevalence of blood-related disorders fuels the blood preparation market's growth.

Technological advancements are emerging as a significant trend in the blood preparation market. Leading companies in this sector are concentrating on developing innovative technological solutions to maintain their competitive edge. For instance, in June 2024, Innobiochips, a biotechnology company based in France, launched Omnys, an advanced blood grouping and testing solution designed to enhance the efficiency and precision of blood transfusion processes. Utilizing patented multiplex technologies, Omnys allows for high-resolution testing of various blood components, including ABO/D typing, phenotyping, extended phenotyping, and antibody screening. This all-in-one system integrates testing devices, reagents, and consumables to optimize workflows, enabling healthcare facilities and laboratories to conduct accurate blood analyses with minimal sample volumes.

Major players in the blood preparation market focus on product innovation, exemplified by advanced blood sampling kits, to improve accuracy and efficiency in blood collection processes. These kits streamline and enhance blood sample collection for diagnostic purposes. Capitainer, in December 2022, launched an upgraded self-sampling blood card collecting a larger volume (2 x 50 microliters), facilitating the measurement of additional biomarkers and enabling a broader range of analyses due to the increased blood quantity for accurate testing of specific substances. This innovation significantly enhances accuracy and ease in blood collection processes.

In October 2022, Pfizer Inc., a pharmaceutical and biotechnology company based in the U.S., acquired Global Blood Therapeutics for $5.4 billion. This acquisition aims to strengthen Pfizer's portfolio in treating sickle cell disease and to meet the critical needs of an underserved patient population. Global Blood Therapeutics Inc. is a U.S.-based biopharmaceutical company that primarily focuses on developing therapies for blood-related disorders, with a particular emphasis on sickle cell disease.

Major companies operating in the blood preparation market include AstraZeneca PLC, Sanofi, LEO Pharma A/S, Bristol-Myers Squibb Company, Baxter International Inc, Pfizer Inc, Portola Pharmaceuticals Inc, GlaxoSmithKline PLC, Bayer AG, Boehringer Ingelheim, Celgene Corp, Shandong East Chemical Industry Co., Xiamen Hisunny Chemical Co. LTD, Merck & Co., Amgen Inc., Takeda Pharmaceutical Company Limited, Novartis AG, Johnson & Johnson, Gilead Sciences Inc., Regeneron Pharmaceuticals Inc., AbbVie Inc., Roche Holding AG, CSL Behring, BioMarin Pharmaceutical Inc., Genentech Inc., Sandoz International GmbH, Medtronic plc, Fresenius Kabi AG, Grifols S.A., HemaCare Corporation, Terumo Corporation.

North America was the largest region in the blood preparation market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global blood preparation market during the forecast period. The regions covered in the blood preparation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the blood preparation market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Blood preparation encompasses the comprehensive process of gathering, processing, and preserving blood and its components for utilization in transfusions or various medical treatments. This intricate procedure involves several stages such as donor screening, blood collection, testing, storage, and eventual transfusion.

The primary categories of blood preparation products include whole blood, blood components, and blood derivatives. Whole blood signifies blood that hasn't been separated into its individual constituents such as red blood cells, white blood cells, and plasma. It contains various antithrombotic and anticoagulant elements, including platelet aggregation inhibitors, fibrinolytics, and anticoagulants, which find applications in transfusions, diagnostics, and research purposes. Key end-users of these blood preparation products encompass hospitals, clinics, blood banks, and other medical facilities involved in managing and administering transfusions and medical treatments requiring blood and its components.

The blood preparation market research report is one of a series of new reports that provides blood preparation market statistics, including blood preparation industry global market size, regional shares, competitors with a blood preparation market share, detailed blood preparation market segments, market trends and opportunities, and any further data you may need to thrive in the blood preparation industry. This blood preparation market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The blood preparation market consists of revenues earned by entities by providing services such as blood processing, blood storing, and distributing blood and blood components for transfusion services. The market value includes the value of related goods sold by the service provider or included within the service offering. The blood preparation market also includes sales of red cells, platelets, cryoprecipitated AHF (CRYO), and granulocytes, which are used in providing blood preparation services. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.